Monday , December 23 2024
Home / Media OutReach / DHL Supply Chain Thailand joins forces with Green Spot to distribute beverages across the nation to support medical staff in their fight against COVID-19

DHL Supply Chain Thailand joins forces with Green Spot to distribute beverages across the nation to support medical staff in their fight against COVID-19

DHL – The logistics company for the world

DHL is the leading global brand in the logistics industry. Our DHL
divisions offer an unrivalled portfolio of logistics services ranging from
national and international parcel delivery, e-commerce shipping and fulfillment
solutions, international express, road, air and ocean transport to industrial
supply chain management. With about 400,000 employees in more than 220
countries and territories worldwide, DHL connects people and businesses
securely and reliably, enabling global sustainable trade flows. With
specialized solutions for growth markets and industries including technology,
life sciences and healthcare, engineering, manufacturing & energy,
auto-mobility and retail, DHL is decisively positioned as “The logistics
company for the world”.

DHL is part of
Deutsche Post DHL Group. The Group generated revenues of more than 66 billion
euros in 2020. With sustainable business practices and a commitment to society
and the environment, the Group makes a positive contribution to the world.
Deutsche Post DHL Group aims to achieve zero-emissions logistics by 2050.

About Green Spot

Vitamilk was established by Green Spot Co. Ltd., a
beverage manufacturer with a long history since 1954. Besides Vitamilk, Green
Spot also produces a wide range of quality products, including Green Spot
orange drink and V-Soy soymilk, all of which are internationally recognized. As
an expert in the production and marketing of soymilk products, the company’s
success is guaranteed by a big volume of exports to more than 50 countries
across the world. The brand is now recognized as one of the world’s biggest manufacturers
of soymilk products.

#DHL


Source link

About admin

Check Also

GangaGen Secures additional US$7.9 Million from CARB-X for Pre-clinical Development of Novel Klebicins Targeting Nosocomial Pneumonia caused by Multidrug-resistant Klebsiella pneumoniae

BANGALORE, INDIA / SINGAPORE – Media OutReach Newswire – 23 December 2024 – GangaGen announced …

Leave a Reply

Your email address will not be published.